• Babak Orandi is an abdominal transplant surgeon and Assistant Professor of Surgery at the University of Alabama at Birmingham, where he is also the surgical director of the Pediatric Liver Transplant Program and surgical director of the Kidney Transplant Accountable Care Team. He completed a combined Bachelors/MD program at the University of Michigan, where he graduated with distinction in research and completed a master’s in clinical investigation. He did his general surgery residency and PhD in clinical investigation at Johns Hopkins, followed by an abdominal transplant surgery fellowship at the University of California, San Francisco. His work has been published in a number of peer-reviewed journals, including the New England Journal of Medicine, BMJ, Annals of Internal Medicine, the American Journal of Transplantation, and Transplantation.
  • Selected Publications

    Academic Article

    Year Title Altmetric
    2022 Donor-reported barriers to living kidney donor follow-upClinical Transplantation.  36. 2022
    2022 First clinical-grade porcine kidney xenotransplant using a human decedent modelAmerican Journal of Transplantation.  22:1037-1053. 2022
    2022 Hepatic macrosteatosis in the US pediatric deceased liver donor populationPediatric Transplantation.  26. 2022
    2022 Abnormal time-zero histology is predictive of kidney transplant outcomesClinical Transplantation2022
    2022 Lost potential and missed opportunities for DCD liver transplantation in the United States 2022
    2021 Clinical and Neurologic Outcomes in Acetaminophen-Induced Acute Liver Failure: A 21-Year Multicenter Cohort StudyClinical Gastroenterology and Hepatology.  19:2615-2625.e3. 2021
    2021 Evaluation of Community-Level Vulnerability and Racial Disparities in Living Donor Kidney TransplantJAMA Surgery.  156:1120-1129. 2021
    2021 Survival following simultaneous liver-lung versus liver alone transplantation: Results of the US national experience 2021
    2021 Everything has a value, except human lifeTransplant International.  34:1571-1572. 2021
    2021 Obesity is a risk factor for progression to kidney transplant waitlisting after liver transplantationClinical Transplantation.  35. 2021
    2021 Self-advocacy is associated with lower likelihood of living donor kidney transplantation 2021
    2021 Early Outcomes With the Liver-kidney Safety NetTransplantation.  105:1261-1272. 2021
    2021 Delayed graft function and acute rejection following HLA-incompatible living donor kidney transplantationAmerican Journal of Transplantation.  21:1612-1621. 2021
    2021 Center-level Variation in HLA-incompatible Living Donor Kidney Transplantation OutcomesTransplantation.  436-442. 2021
    2021 Competing risks and the risks of children and adults competing for liversAmerican Journal of Transplantation.  21:13-14. 2021
    2021 Early Kidney Allograft Failure after Simultaneous Liver-kidney Transplantation: Evidence for Utilization of the Safety Net?Transplantation.  816-823. 2021
    2021 Patient survival following third time liver transplant in the United States in the MELD era 2021
    2020 Impact of ABO-Incompatible Living Donor Kidney Transplantation on Patient SurvivalAmerican Journal of Kidney Diseases.  76:616-623. 2020
    2020 Bariatric surgery to achieve transplant in end-stage organ disease patients: A systematic review and meta-analysis 2020
    2020 Combined Thoracic-Kidney Transplantation Practices May Exacerbate Existing Geographic Disparities in Access to Deceased Donor Kidney Transplantation 2020
    2020 Tackling the weight list problemAmerican Journal of Transplantation.  20:329-330. 2020
    2020 Impact of Donor Hepatitis C Virus on Kidney Transplant Outcomes for Hepatitis C-positive Recipients in the Direct-acting Antiviral Era: Time to Revise the Kidney Donor Risk Index?Transplantation.  1215-1228. 2020
    2019 Donation approval among obese living kidney donor candidates: The impact of metabolic syndromeSurgery.  166:940-946. 2019
    2019 Mitigating Racial and Sex Disparities in Access to Living Donor Kidney Transplantation: Impact of the Nation's Longest Single-center Kidney ChainAnnals of Surgery.  270:639-646. 2019
    2019 Prediction system for risk of allograft loss in patients receiving kidney transplants: International derivation and validation studyBMJ.  366. 2019
    2019 Assessment of Trends in Transplantation of Liver Grafts from Older Donors and Outcomes in Recipients of Liver Grafts from Older Donors, 2003-2016JAMA Surgery.  154:441-449. 2019
    2019 The effect of an organ procurement experience on preclinical medical student perceptions of transplant surgeryClinical Transplantation.  33. 2019
    2019 Banff survey on antibody-mediated rejection clinical practices in kidney transplantation: Diagnostic misinterpretation has potential therapeutic implicationsAmerican Journal of Transplantation.  19:123-131. 2019
    2018 Utilization, patency, and complications associated with vascular access for hemodialysis in the United StatesJournal of Vascular Surgery.  68:1166-1174. 2018
    2018 Transfusion of leukoreduced blood products and risk of antibody-mediated rejection of renal allograftsTransfusion.  58:1951-1957. 2018
    2018 Intraoperative Management of Liver Transplant Patients Without the Routine Use of Renal Replacement TherapyTransplantation.  102:e229-e235. 2018
    2018 Surgical approach, cost, and complications of appendectomy in kidney transplant recipientsClinical Transplantation.  32. 2018
    2018 Hospital readmissions following HLA-incompatible live donor kidney transplantation: A multi-center studyAmerican Journal of Transplantation.  18:650-658. 2018
    2018 Complement-Activating Anti-HLA Antibodies in Kidney Transplantation: Allograft Gene Expression Profiling and Response to TreatmentJournal of the American Society of Nephrology.  29:620-635. 2018
    2017 The Incremental Cost of Incompatible Living Donor Kidney Transplantation: A National Cohort AnalysisAmerican Journal of Transplantation.  17:3123-3130. 2017
    2017 Ureteral Obstruction and New Groin Pain in a Kidney Transplant RecipientAmerican Journal of Transplantation.  17:1139-1141. 2017
    2017 The Dawn of Transparency: Insights from the Physician Payment Sunshine Act in Plastic SurgeryAnnals of Plastic Surgery.  78:315-323. 2017
    2017 Here Comes the Sunshine: Industry's Payments to Cardiothoracic SurgeonsAnnals of Thoracic Surgery.  103:567-572. 2017
    2017 The Banff 2015 Kidney Meeting Report: Current Challenges in Rejection Classification and Prospects for Adopting Molecular PathologyAmerican Journal of Transplantation.  17:28-41. 2017
    2016 Plasma-Derived C1 Esterase Inhibitor for Acute Antibody-Mediated Rejection Following Kidney Transplantation: Results of a Randomized Double-Blind Placebo-Controlled Pilot StudyAmerican Journal of Transplantation.  16:3468-3478. 2016
    2016 Mortality and Rates of Graft Rejection or Failure Following Intestinal Transplantation in Patients With vs Without Crohn's DiseaseClinical Gastroenterology and Hepatology.  14:1574-1581. 2016
    2016 Recurrent IgA Nephropathy After Kidney TransplantationTransplantation Proceedings.  48:2689-2694. 2016
    2016 Splenic irradiation for the treatment of severe antibody-mediated rejectionAmerican Journal of Transplantation.  16:3041-3045. 2016
    2016 Induction Immunosuppression and Clinical Outcomes in Kidney Transplant Recipients Infected With Human Immunodeficiency VirusAmerican Journal of Transplantation.  16:2368-2376. 2016
    2016 The authors replyNew England Journal of Medicine.  375:288-289. 2016
    2016 Long-Term Renal Function in Living Kidney Donors Who Had Histological Abnormalities at DonationTransplantation.  100:1294-1298. 2016
    2016 Economic Impacts of ABO-Incompatible Live Donor Kidney Transplantation: A National Study of Medicare-Insured RecipientsAmerican Journal of Transplantation.  16:1465-1473. 2016
    2016 Survival benefit with kidney transplants from HLA-incompatible live donorsNew England Journal of Medicine.  374:940-950. 2016
    2016 Presentation and outcomes of C4d-negative antibody-mediated rejection after kidney transplantationAmerican Journal of Transplantation.  16:213-220. 2016
    2016 Where the Sun shines: Industry's payments to transplant surgeonsAmerican Journal of Transplantation.  16:292-300. 2016
    2015 Center-level variation in the development of delayed graft function after deceased donor kidney transplantationTransplantation.  99:997-1002. 2015
    2015 Frailty, mycophenolate reduction, and graft loss in kidney transplant recipientsTransplantation.  99:805-810. 2015
    2015 Choosing the order of deceased donor and living donor kidney transplantation in pediatric recipients: A Markov decision process modelTransplantation.  99:360-366. 2015
    2015 A closer look at rituximab induction on HLA antibody rebound following HLA-incompatible kidney transplantationKidney International.  87:409-416. 2015
    2015 Loss of pediatric kidney grafts during the "high-risk age window": Insights from pediatric liver and simultaneous liver-kidney recipientsAmerican Journal of Transplantation.  15:445-452. 2015
    2015 Quantifying renal allograft loss following early antibody-mediated rejectionAmerican Journal of Transplantation.  15:489-498. 2015
    2015 Frailty and mortality in kidney transplant recipientsAmerican Journal of Transplantation.  15:149-154. 2015
    2014 Patient- And Provider-Reported Information about Transplantation and Subsequent WaitlistingJournal of the American Society of Nephrology.  25:2871-2877. 2014
    2014 Eculizumab prevents recurrent antiphospholipid antibody syndrome and enables successful renal transplantationAmerican Journal of Transplantation.  14:459-465. 2014
    2014 Assessment of resident and fellow knowledge of the organ donor referral processClinical Transplantation.  28:443-449. 2014
    2014 Eculizumab and splenectomy as salvage therapy for severe antibody-mediated rejection after HLA-incompatible kidney transplantationTransplantation.  98:857-863. 2014
    2014 National trends over 25 years in pediatric kidney transplant outcomesPediatrics.  133:594-601. 2014
    2014 Outcomes of nonelective weekend admissions for lower extremity ischemiaJournal of Vascular Surgery.  60:1572-1579.e1. 2014
    2014 Quantifying the risk of incompatible kidney transplantation: A multicenter studyAmerican Journal of Transplantation.  14:1573-1580. 2014
    2013 Order of donor type in pediatric kidney transplant recipients requiring retransplantationTransplantation.  96:487-493. 2013
    2013 Age at graft loss after pediatric kidney transplantation: Exploring the high-risk age windowClinical Journal of the American Society of Nephrology.  8:1019-1026. 2013
    2013 The aggressive phenotype revisited: Utilization of higher-risk liver allograftsAmerican Journal of Transplantation.  13:936-942. 2013
    2011 Surgical mentors' and mentees' productivity from 1993 to 2006 2011
    2011 Ethics and the law: Is there common ground on informed consent for disparities in hospital outcomes?Annals of Internal Medicine.  155:260-264. 2011
    2010 Development of "Imageable" Beads for Transcatheter Embolotherapy 2010
    2009 A population-based analysis of endovascular versus open thoracic aortic aneurysm repairJournal of Vascular Surgery.  49:1112-1116. 2009
    2009 The escalating importance of clinical researchThe virtual mentor : VM.  11:277-278. 2009


    Year Title Altmetric
    2013 Complications of endovascular aneurysm repair.  90-101. 2013
    2012 Acute mesenteric ischemia.  426-430. 2012
    2012 Know what to look for when patients with post-ercp complications present to the emergency department.  25-27. 2012

    Education And Training

  • Doctor of Philosophy in Health Professions and Related Programs, Johns Hopkins University 2014
  • Doctor of Medicine, University of Michigan 2008
  • Master of Sciences or Mathematics in Clinical Research Coordinator, University of Michigan 2007
  • Bachelor of Arts in Biomedical Sciences, University of Michigan 2001
  • Full Name

  • Babak Orandi